Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Author:

Buyyounouski Mark K.1,Choyke Peter L.2,McKenney Jesse K.3,Sartor Oliver4,Sandler Howard M.5,Amin Mahul B.6,Kattan Michael W.7ORCID,Lin Daniel W.8

Affiliation:

1. Associate Professor of Radiation Oncology, Department of Radiation Oncology; Stanford University; Stanford CA

2. Director, Molecular Imaging Program; National Cancer Institute; Rockville MD

3. Section Head, Surgical Pathology, Robert J. Tomisch Pathology and Laboratory Medicine Institute; Cleveland Clinic; Cleveland OH

4. Hematology/Oncology Section Chief and Professor of Radiation Oncology, Departments of Medicine and Urology; Tulane Medical School; New Orleans LA

5. Chair, Department of Radiation Oncology, and Professor of Radiation Oncology; Cedars-Sinai Medical Center; Los Angeles CA

6. Chair, Department of Pathology and Laboratory Medicine; University of Tennessee Health Science Center; Memphis TN

7. Chair, Department of Quantitative Health Sciences; Cleveland Clinic; Cleveland OH

8. Chief of Urologic Oncology, Department of Urology, University of Washington, and Division of Public Health Sciences; Fred Hutchinson Cancer Research Center; Seattle WA

Publisher

Wiley

Subject

Oncology,Hematology

Reference28 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin.,2017

2. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working Group 2: T2 substaging and prostate cancer volume;Kwast;Mod Pathol.,2011

3. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system;Epstein;Am J Surg Pathol.,2016

4. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine;Kattan;CA Cancer J Clin.,2016

5. Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy;Halabi;J Natl Cancer Inst.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3